Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus - Wikidata - awgldk - TriplyDB

Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus

Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus

http://www.wikidata.org/entity/Q58376682

about

Role of stem cells during diabetic liver injury Hepatitis C genotype 4: The past, present, and future Hepatitis C virus infection and type 1 and type 2 diabetes mellitus Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV Cytokinome profile of patients with type 2 diabetes and/or chronic hepatitis C infection Global epidemiology and burden of HCV infection and HCV-related disease.Management strategies for hepatocellular carcinoma: old certainties and new realities.CARING (CAncer Risk and INsulin analoGues): the association of diabetes mellitus and cancer risk with focus on possible determinants - a systematic review and a meta-analysis Insight into the impact of diabetes mellitus on the increased risk of hepatocellular carcinoma: mini-review Declining rates of hepatocellular carcinoma in urban Shanghai: incidence trends in 1976-2005.Insulin resistance is associated with hepatocellular carcinoma in chronic hepatitis C infection.Glycated hemoglobin and antidiabetic strategies as risk factors for hepatocellular carcinoma.Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma.The role of pre-existing diabetes mellitus on hepatocellular carcinoma occurrence and prognosis: a meta-analysis of prospective cohort studies.Continuation of metformin use after a diagnosis of cirrhosis significantly improves survival of patients with diabetes.First multicenter study for risk factors for hepatocellular carcinoma development in North Africa.Impact of diabetes mellitus on the prognosis of patients with hepatocellular carcinoma after curative hepatectomy.Distribution and clinical correlates of viral and host genotypes in Chinese patients with chronic hepatitis C virus infection Effects of statins on the risk of hepatocellular carcinoma Poor Perception of Body Weight Category amongst the Overweight and Obese with Chronic Hepatitis C: A Target for Intervention Viusid, a nutritional supplement, increases survival and reduces disease progression in HCV-related decompensated cirrhosis: a randomised and controlled trial Association of HCV with diabetes mellitus: an Egyptian case-control study.Chronic hepatitis c genotype-4 infection: role of insulin resistance in hepatocellular carcinoma.Efficacy and safety of sitagliptin for the treatment of diabetes mellitus complicated by chronic liver injury Potential role of leptin, adiponectin and three novel adipokines--visfatin, chemerin and vaspin--in chronic hepatitis.Diabetes mellitus is associated with increased mortality in patients receiving curative therapy for hepatocellular carcinoma.Diabetes and Hepatitis C: A Two-Way Association.Natural evolution of hepatitis C virus infection in hemodialysis Tunisian patients and CTLA-4 SNP's.Diabetes mellitus and renal involvement in chronic viral liver disease.Body mass index and risk of primary liver cancer: a meta-analysis of prospective studies Current concepts in hepatic resection for hepatocellular carcinoma in cirrhotic patients Hepatitis B- and hepatitis C-related hepatocellular carcinomas in the United States: similarities and differences A critical role of STAT1 in streptozotocin-induced diabetic liver injury in mice: controlled by ATF3.Inhibition of hepatocellular carcinoma by PegIFNα-2a in patients with chronic hepatitis C: a nationwide multicenter cooperative study.Diabetes mellitus and risk of hepatocellular carcinoma: findings from the Singapore Chinese Health Study.The Relation between Obesity and Survival after Surgical Resection of Hepatitis C Virus-Related Hepatocellular Carcinoma.Prospective evaluation of type 2 diabetes mellitus on the risk of primary liver cancer in Chinese men and women.Is exposure to Agent Orange a risk factor for hepatocellular cancer?-A single-center retrospective study in the U.S. veteran population.Liver cirrhosis and diabetes: risk factors, pathophysiology, clinical implications and management Viral clearance is associated with improved insulin resistance in genotype 1 chronic hepatitis C but not genotype 2/3

P2860

Q26773551-4F4A0A88-87CE-45F6-8EA2-313FCE3CF463 Q26775815-5D153122-B1A4-48DA-B6A9-DD1D64F45625 Q26829202-40713A99-1424-4F52-B0FA-B8BB9D540DFA Q28079826-22E4EF77-4D9C-4FA2-94F4-145614DFE3CD Q28480545-A6822910-447F-47A2-926E-E5EF652622EC Q30240220-273CBE22-6768-439E-88E5-6BA3B6BB93B0 Q30252143-C407C949-D447-4FE3-AF58-9C7715B76CF1 Q33646525-FCCBD8DF-B1DA-4056-8720-6E2A66D394F0 Q33731768-ED088F79-8D97-4438-BD0C-AD54B1D8738D Q33816094-E878B07A-FF7A-4072-BB49-F7C4EA2BDE1E Q33844192-22F22577-41CF-4FD7-B7F7-780E7A764A86 Q33935606-9D78F43F-AC47-428F-88E1-6C747D7CA9CE Q34008552-60BED183-96AD-4EA1-B265-1362CCB052A6 Q34113485-F9E3B294-0053-4E3E-B1D1-79BDB3A3F89F Q34446161-B6E063FD-5525-4904-AEA5-3EDBFF4DA445 Q34560817-B8C234A4-10DF-4CDD-BB5A-2C4B8505D688 Q34600849-B026BFBF-B0BD-4948-AF02-8E3D6B94DFD4 Q34746864-02E6FD3A-E1CE-43AD-8E3D-D1E6CEF6933F Q34997752-292368F2-57ED-40B5-AD67-2DC0FA697882 Q35105334-F0102089-5C61-4601-8954-11124296571D Q35322521-F21A2DEC-6EC9-4C51-B93E-CD57D919F145 Q35427376-FF71F9A7-1694-4121-8018-3ED1CBB61F12 Q35555547-D265731D-FFA3-4E09-B6D8-25E62F3C6B13 Q35849028-C44BE734-2903-4022-9C8E-5BB421AC313E Q35876759-E11DB89F-8D8B-4AA6-BBB9-8E470E45242A Q36051537-EF1EA5AA-2FA4-4134-9226-2EFFEE14807A Q36056076-4C16590C-B159-4F1D-B339-76971ED84E3A Q36067577-97CE29ED-93E0-4665-948E-FBBF54CAF56C Q36309960-33109B5A-208C-4ACA-B747-ECF20D63E621 Q36405672-42051DAA-4AC9-4547-BF62-D5CE6D537494 Q36429818-78680758-3A70-42ED-9DE9-91B6C8A4533A Q36454775-6B3D4DF7-6BB5-4C69-A881-E0D0693E7B4F Q36655185-60B86663-71A1-411D-AC07-CC9DCCE5CA4A Q36745162-A26F9881-634A-423D-99B9-D5AF11A47CD2 Q36746724-C78AE8C3-F9AD-43B3-ABF1-D99B8AF0820F Q36848551-351E6A2F-AC3E-4AB5-AEB2-0F70F306849D Q36862827-048D0E17-B773-4685-BE06-694A5C438170 Q36937018-8D5915B2-5F5A-4982-B70E-E054E6F01FE0 Q37122216-4742203C-DCDB-4BDA-8322-8B88394C427E Q37155511-8EFF020E-2969-47D7-B14E-2957C6C67650

P2860

Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus

http://www.wikidata.org/entity/Q58376682

description

article

@en

im Jahr 2008 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2008

@uk

name

Increased risk of hepatocellul ...... irrhosis and diabetes mellitus

@en

Increased risk of hepatocellul ...... irrhosis and diabetes mellitus

@nl

type

label

Increased risk of hepatocellul ...... irrhosis and diabetes mellitus

@en

Increased risk of hepatocellul ...... irrhosis and diabetes mellitus

@nl

prefLabel

Increased risk of hepatocellul ...... irrhosis and diabetes mellitus

@en

Increased risk of hepatocellul ...... irrhosis and diabetes mellitus

@nl

P1433

Q58376682-C0EEC516-2D74-4C76-BE10-439489D90399

P1476

Q58376682-1C3F1998-C675-4D59-BB6C-37EF53B33C0E

P2093

Q58376682-10CAC3EF-343F-4273-8F9C-BB6E279C2D59

Q58376682-34722BA2-6C04-427A-ACD2-4B16BA05218C

Q58376682-4735ECB8-FE29-4284-A24F-51E6FE65121C

Q58376682-68674F37-09D5-4E57-943F-98A8F0503BC7

Q58376682-7475162B-1EB1-4081-B222-D2B2FCE64341

Q58376682-7ED5A96B-8B9F-4752-8CD3-AA4011F1B8C1

Q58376682-84407380-FF1D-43D4-AF19-C432B3F12F58

Q58376682-85C35A6D-5BD0-4EC8-B24F-CFBD15F4AB73

Q58376682-A3901F3F-E110-45B2-9732-198763387FB5

Q58376682-BD60264D-765F-457D-B5EB-FF0E0E04618F

P2860

Q58376682-34D565E2-EF8F-47B1-AB99-CF2FEAC8D3E2

Q58376682-E5C72864-726B-43D0-BE36-AF51BC135E94

P304

Q58376682-D6B38EB1-BF61-430A-BC50-724F7C450D18

P31

Q58376682-9B471DB1-A69A-43ED-A2D5-3449AA47DF20

P356

Q58376682-C8B92BAE-6892-45C2-BDD7-0AD4AE8163B3

P407

Q58376682-18A839F0-6337-4453-88D0-1B735A5773A2

P433

Q58376682-B2365417-FD1E-481B-A0DD-2908AD41DC57

P478

Q58376682-3777A3E9-42E9-4966-9551-5CE77C2C60B3

P50

Q58376682-1415422C-37C1-47E0-9CA8-9DDB6ABB12BE

P577

Q58376682-7803320B-972F-402E-A281-5636A121A26F

P698

Q58376682-6B3287B6-BF52-42F5-BA43-BF9471030027

P921

Q58376682-050E4DF7-19E9-48F3-990C-C3D0A0154EA0

Q58376682-C2EC9552-8156-46DA-BCF9-8CEFBEDB3394

P356

P1433

P1476

Increased risk of hepatocellul ...... irrhosis and diabetes mellitus

@en

P2093

Bart J. Veldt

http://www.w3.org/2001/XMLSchema#string

E. Jenny Heathcote

http://www.w3.org/2001/XMLSchema#string

Harry L. A. Janssen

http://www.w3.org/2001/XMLSchema#string

Heiner Wedemeyer

http://www.w3.org/2001/XMLSchema#string

Juerg Reichen

http://www.w3.org/2001/XMLSchema#string

Michael P. Manns

http://www.w3.org/2001/XMLSchema#string

Robert J. de Knegt

http://www.w3.org/2001/XMLSchema#string

Solko W. Schalm

http://www.w3.org/2001/XMLSchema#string

Stefan Zeuzem

http://www.w3.org/2001/XMLSchema#string

W. Peter Hofmann

http://www.w3.org/2001/XMLSchema#string

P2860

Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States.

Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis.

P304

1856-1862

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.22251

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

47

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18506898

http://www.w3.org/2001/XMLSchema#string

P921

liver cirrhosis